| 25 May 2026 |
BPC157 5mg + TB500 5mg Blend |
7.7 |
20mg |
24.9mg |
+24.7% |
98.43% |
Lab B |
| 24 May 2026 |
Selank |
6.7 |
20mg |
17.4mg |
-13.1% |
98.00% |
Lab C |
| 24 May 2026 |
Abaloparatide |
10.0 |
30mg |
28.3mg |
-5.6% |
99.59% |
Lab G |
| 24 May 2026 |
T3 (Liothyronine) |
7.5 |
10mg |
11.5mg |
+14.9% |
99.65% |
Lab C |
| 24 May 2026 |
Vilon |
6.4 |
20mg |
17.4mg |
-12.9% |
96.69% |
Lab F |
| 23 May 2026 |
Crystagen |
5.3 |
15mg |
16.6mg |
+10.7% |
97.42% |
Lab B |
| 23 May 2026 |
Super Shred |
5.9 |
250mg/ml |
236.1mg/ml |
-5.6% |
97.51% |
Lab C |
| 23 May 2026 |
BPC-157 Arg Oral |
5.5 |
100mg |
105.6mg |
+5.6% |
99.03% |
Lab C |
| 23 May 2026 |
Tirzepatide 30mg Pen Kit |
6.1 |
20mg |
24.5mg |
+22.7% |
96.40% |
Lab F |
| 23 May 2026 |
YK-11 Raw |
6.9 |
10g |
9.8g |
-1.7% |
99.50% |
Lab F |
| 21 May 2026 |
Tamoxifen (Nolvadex) |
6.7 |
25mg |
25.1mg |
+0.3% |
99.13% |
Lab D |
| 20 May 2026 |
CJC-1295 With DAC |
7.4 |
10mg |
9.3mg |
-6.8% |
98.76% |
Lab F |
| 19 May 2026 |
Ivermectin |
10.0 |
20mg |
23.9mg |
+19.6% |
99.49% |
Lab B |
| 17 May 2026 |
Halotestin (Fluoxymesterone) |
5.3 |
20mg |
22.2mg |
+11.1% |
96.74% |
Lab F |
| 17 May 2026 |
Thymalin |
7.5 |
5mg |
4.9mg |
-2.6% |
95.70% |
Lab F |
| 29 Jan 2026 |
BAM15 |
5.6 |
100mg |
100.4mg |
+0.4% |
99.91% |
Lab C |
| 29 Jan 2026 |
Semax |
4.2 |
30mg |
29.2mg |
-2.7% |
98.29% |
Lab D |
| 26 Jan 2026 |
Blend 300 (TRA/Mast P/Test P) |
5.7 |
300mg/ml |
330.4mg/ml |
+10.1% |
97.54% |
Lab C |
| 26 Jan 2026 |
Masteron P (Drostanolone P) |
5.6 |
250mg/ml |
232.7mg/ml |
-6.9% |
99.74% |
Lab E |
| 9 Jan 2026 |
AA Water |
10.0 |
2mg |
2.4mg |
+20.1% |
95.96% |
Lab D |
| 9 Jan 2026 |
Retatrutide 30mg Pen Kit |
6.6 |
2mg |
1.9mg |
-6.3% |
95.61% |
Lab B |
| 9 Jan 2026 |
Telmisartan |
5.7 |
100mg |
104.6mg |
+4.6% |
98.00% |
Lab F |
| 6 Jan 2026 |
APAA (alpha-phenylacetoacetamide) CAS 102-01-2 |
7.8 |
500g |
484.3g |
-3.1% |
99.82% |
Lab G |
| 6 Jan 2026 |
Trenbolone Enanthate |
4.0 |
200mg/ml |
245.2mg/ml |
+22.6% |
95.30% |
Lab G |
| 29 Dec 2025 |
Winstrol Oil (Stanozolol) |
6.3 |
200mg/ml |
246.0mg/ml |
+23.0% |
96.03% |
Lab A |
| 12 Dec 2025 |
Testosterone Decanoate Raw |
6.8 |
5g |
4.3g |
-14.2% |
98.99% |
Lab F |
| 5 Dec 2025 |
Equipoise (Boldenone Undecylenate) |
7.6 |
200mg/ml |
176.8mg/ml |
-11.6% |
99.80% |
Lab G |
| 23 Nov 2025 |
Dutasteride |
5.8 |
10mg |
11.2mg |
+11.9% |
97.12% |
Lab B |
| 17 Nov 2025 |
Cardiogen |
7.0 |
15mg |
17.1mg |
+13.9% |
97.84% |
Lab E |
| 17 Nov 2025 |
Lipo-C 120mg |
6.6 |
100mg/ml |
116.0mg/ml |
+16.0% |
96.40% |
Lab G |
| 14 Nov 2025 |
Epithalon |
6.3 |
2mg |
2.4mg |
+21.1% |
97.95% |
Lab E |
| 14 Nov 2025 |
FOXO4 |
5.9 |
10mg |
9.8mg |
-2.0% |
98.08% |
Lab A |
| 5 Nov 2025 |
Methylene Blue |
6.3 |
50mg |
52.5mg |
+5.0% |
98.16% |
Lab D |
| 4 Nov 2025 |
ACE-031 |
4.0 |
5mg |
6.0mg |
+20.7% |
98.72% |
Lab D |
| 23 Oct 2025 |
Retatrutide |
10.0 |
10mg |
9.68mg |
-3.2% |
99.88% |
Lab E |
| 21 Oct 2025 |
Retatrutide |
7.0 |
10mg |
10.1mg |
+1.0% |
99.51% |
Lab E |
| 17 Oct 2025 |
GHRP-2 Acetate |
4.6 |
50mg |
60.6mg |
+21.2% |
95.55% |
Lab B |
| 17 Oct 2025 |
SLU-PP-332 |
4.9 |
10mg |
9.3mg |
-7.2% |
97.80% |
Lab F |
| 9 Oct 2025 |
Cerebrolysin |
5.9 |
15mg |
13.4mg |
-10.4% |
95.22% |
Lab D |
| 5 Oct 2025 |
Retatrutide |
0.0 |
10mg |
⚠️ Sample does not contain Retatrutide |
(no batch ID) |
No Label / Silver Crimp / Clear Blue Cap |
|
| 3 Oct 2025 |
Retatrutide |
7.4 |
5mg |
4.71mg |
-5.8% |
99.75% |
Lab E |
| 3 Oct 2025 |
BAC Water |
10.0 |
15mg |
13.5mg |
-9.9% |
95.71% |
Lab G |
| 3 Oct 2025 |
EPO |
6.6 |
10mg |
8.8mg |
-12.3% |
97.83% |
Lab B |
| 3 Oct 2025 |
KPV |
4.0 |
5mg |
5.7mg |
+14.5% |
99.01% |
Lab G |
| 10 Sep 2025 |
Retatrutide |
9.0 |
5mg |
4.62mg |
-7.6% |
99.83% |
Lab E |
| 1 Sep 2025 |
Retatrutide |
6.2 |
5mg |
6.17mg |
+23.4% |
99.59% |
Lab F |